表紙
市場調査レポート

血液検査の世界市場 (2015〜2019年)

Blood Screening Market - Global Market Research 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 342083
出版日 ページ情報 英文 74 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
血液検査の世界市場 (2015〜2019年) Blood Screening Market - Global Market Research 2015-2019
出版日: 2015年10月14日 ページ情報: 英文 74 Pages
概要

世界の血液検査市場は、2014年から2019年にかけて9.31%のCAGRで拡大すると予測されています。

当レポートでは、世界の血液検査市場について分析し、市場の概要や構造、市場規模の動向 (今後5年間の予測値)、技術・製品・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・推計しております。

第1章 エグゼクティブサマリー

第2章 調査範囲

  • 調査概要
  • 主要ベンダーの製品

第3章 市場調査手法

  • 調査手法
  • 経済指標

第4章 イントロダクション

第5章 市場環境

  • 市場概要
  • 市場規模・予測
  • ファイブフォース分析

第6章 市場区分:技術別

  • NAAT
  • マルチプレックスリアルタイムPCR

第7章 市場区分:製品別

  • アッセイ・消耗品
  • 装置
  • サービス

第8章 地域区分

  • 南北アメリカの血液検査システム市場
  • EMEA (欧州・中東・アフリカ) 市場
  • APAC (アジア太平洋地域) 市場

第9章 市場促進要因

  • 献血の増加
  • 血液安全性の認識
  • オーダーメイド医療の進歩

第10章 促進要因の影響

第11章 市場の課題

  • クローズドシステムの限界
  • 規制問題
  • 熟練技術者の不足
  • 複雑性・低い検出能力

第12章 促進要因・課題の影響

第13章 市場動向

  • NAATの実行
  • 希少疾患・難治性疾患調査におけるイニシアチブ
  • 戦略的アライアンス
  • ITの進歩

第14章 ベンダー環境

  • 競合状況
  • 市場シェア分析
  • その他の有力ベンダー

第15章 主要ベンダーの分析

  • Abbott Diagnostics
  • bioMerieux
  • Grifols
  • Roche Diagnostics

第16章 付録

  • 略語集

第17章 Technavioについて

図表一覧

目次
Product Code: IRTNTR7295

About blood screening

Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. The major blood tests that are extensively used for diagnosing diseases include erythrocyte sedimentation rate (ESR), full blood count (FBC), electrolyte test, karyotyping, enzyme-linked immunosorbent assay (ELISA), C-reactive protein, liver function test, and blood cholesterol test. The market for blood screening has witnessed numerous technological advances such as shift toward the first-generation ELISA to highly advanced NAAT testing, since its inception.

Technavio's analysts forecast the global blood screening market to grow at a CAGR of 9.31% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global blood screening market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of instruments, assays/consumables, and services for the technologies such as NAAT and multiplexed real-time PCR

Technavio's report, Global Blood Screening Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global blood screening market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • APAC
  • Europe
  • Latin America
  • MEA
  • North America

Key vendors

  • Abbott Diagnostics
  • bioMerieux
  • Grifols
  • Roche Diagnostics

Other Prominent Vendors

  • Alere
  • BD
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic
  • Immunetics
  • Lab21
  • Meridian Bioscience
  • OraSure
  • Ortho Clinical Diagnostics
  • Qiagen
  • SeraCare
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech

Market driver

  • Increase in number of blood donations
  • For a full, detailed list, view our report

Market challenge

  • Limitation of closed system
  • For a full, detailed list, view our report

Market trend

  • Adoption of NAAT
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by technology

  • NAAT
  • Multiplexed real-time PCR

PART 07: Market segmentation by product

  • Assays and consumables
  • Instruments
  • Services

PART 08: Geographical segmentation

  • Blood screening systems market in Americas
  • Blood screening systems market in EMEA
  • Blood screening systems market in APAC

PART 09: Market drivers

  • Increase in blood donations
  • Awareness of blood safety
  • Advances in personalized medicine

PART 10: Impact of drivers

PART 11: Market challenges

  • Limitation of closed systems
  • Regulatory issues
  • Lack of skilled technicians
  • Complexity and low detection capability

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Implementation of NAAT
  • Initiatives in rare disease research
  • Strategic alliances
  • Advances in IT

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 15: Key vendor analysis

  • Abbott Diagnostics
  • bioMerieux
  • Grifols
  • Roche Diagnostics

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global blood screening systems market segmentation
  • Exhibit 03: Global blood screening systems market 2014-2019 ($ billions)
  • Exhibit 04: Five forces analysis
  • Exhibit 05: Global blood screening systems market segmentation by technology
  • Exhibit 06: Global NAAT systems market segmentation by adoption 2014
  • Exhibit 07: Grifols: Global NAAT systems market share 2014
  • Exhibit 08: Grifols: NAAT systems market share in US 2014
  • Exhibit 09: Grifols: NAAT systems market share in APAC 2014
  • Exhibit 10: Roche Diagnostics and Grifols: Global NAAT systems market share 2014
  • Exhibit 11: Percentage share of products used for blood screening 2014
  • Exhibit 12: Comparison of NAAT systems for simultaneous detection of HIV, HCV (RNA), and HBV (DNA)
  • Exhibit 13: Global NAAT systems market 2014-2019 ($ billions)
  • Exhibit 14: Global multiplexed real-time PCR systems market 2014-2019 ($ billions)
  • Exhibit 15: Global blood screening systems market segmentation by technology 2014
  • Exhibit 16: Global blood screening systems market segmentation by technology 2019
  • Exhibit 17: Global blood screening systems market segmentation by technology 2014-2019
  • Exhibit 18: Global blood screening systems market segmentation by product
  • Exhibit 19: Global blood screening systems market segmentation by product 2014
  • Exhibit 20: Global blood screening systems market segmentation by geography 2014
  • Exhibit 21: Global blood screening systems market segmentation by geography 2019
  • Exhibit 22: Global blood screening systems market segmentation by geography 2014-2019
  • Exhibit 23: List of blood donation organizations in Americas
  • Exhibit 24: Blood screening systems market in Americas 2014-2019 ($ billions)
  • Exhibit 25: List of blood donation organizations in Europe
  • Exhibit 26: Number of healthcare facilities in Europe with NAAT systems
  • Exhibit 27: Application of NAAT systems in Europe
  • Exhibit 28: Blood screening systems market in EMEA 2014-2019 ($ billions)
  • Exhibit 29: List of blood donation organizations in APAC
  • Exhibit 30: Blood screening systems market in APAC 2014-2019 ($ billions)
  • Exhibit 31: Impact of drivers
  • Exhibit 32: Impact of drivers and challenges
  • Exhibit 33: NAATs for blood screening
  • Exhibit 34: Difference between NAAT and ELISA
  • Exhibit 35: Global blood screening systems market: Ranking of companies 2014
  • Exhibit 36: Grifols: Key takeaways
  • Exhibit 37: Roche Diagnostics: Key takeaways
  • Exhibit 38: Abbott Diagnostics: Key takeaways
  • Exhibit 39: bioMerieux: Key takeaways
  • Exhibit 40: Abbott Diagnostics: Key business offerings
  • Exhibit 41: bioMerieux: Clinical applications
  • Exhibit 42: Grifols: Business segmentation by revenue 2014
  • Exhibit 43: Grifols: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 44: Grifols: Geographical segmentation by revenue 2014
Back to Top